Rain Enhancement Technologies Holdco Inc

Aktienanalyse zu Rain Enhancement Technologies Holdco Inc (RAIN)

$0.985

-0.024 (-2.48%)Zum Schluss

Loading chart…
High
1.040
Open
1.030
VWAP
1.00
Vol
108.89K
Mkt Cap
44.03M
Low
0.970
Amount
108.71K
EV/EBITDA, TTM
0.00

Rain Enhancement Technologies Holdco, Inc. is engaged in developing rainfall generation technology. The Company is focused on developing, manufacturing and commercializing ionization rainfall generation technology to provide additional rainfall for industries, supranational organizations, countries and localities. It focuses on building its core platform with software, meteorology, hardware, product design and operations to make rainfall generation more dependable. It focuses on improving on existing rainfall generation technologies by introducing measurement tools, including automation technology, rain gauges, and weather stations. The rainfall generation platform ionizes the surrounding air similar to how air purifiers work. It intends to enhance agricultural, industrial and household water supplies for all the communities in which it operates by developing technology and services to serve governmental and commercial clients’ needs.

AI analysis of Rain Enhancement Technologies Holdco Inc (RAIN)

sell

Rain Oncology Inc. is not a good buy right now due to its significant financial losses and lack of revenue. The stock has a current price of 0.98, a year-to-date change of -80.30%, and a forward P/E ratio of 0, indicating no expected earnings growth. The main risk is its negative net income of -3,246,657 in the latest quarter, which raises concerns about its financial viability.

Bewertungskennzahlen

The current forward P/E ratio for Rain Enhancement Technologies Holdco Inc (RAIN) is 0.00, compared to its 5-year average forward P/E of -0.88.

Forward P/E

Strongly Overvalued
5Y Average P/E
-0.88
Current P/E
0.00
Überbewertet
-0.75
Unterbewertet
-1.01

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.91
Current EV/EBITDA
0.00
Überbewertet
1.02
Unterbewertet
0.81

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Überbewertet
0.00
Unterbewertet
0.00

Alphio AI Price Scenarios for RAIN

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%RAIN

$4.56

Szenariopreis

B

Base

Base · 50%RAIN

$3.88

Szenariopreis

B

Bear

Bear · 25%RAIN

$3.37

Szenariopreis

Whales holding RAIN

A

Apollo Global Management, Inc.

+ HoldingRAIN

-15.68%

3M Return

Event-Zeitleiste

2026-08-06 (ET)

10:00:00

Rain Enhancement Technologies Signs Exclusive Agreement with Turkish Company

2026-06-30 (ET)

17:30:00

Rain Enhancement Technologies Files $25M Mixed Securities Shelf

2026-03-31 (ET)

09:40:00

Rain Enhancement Technologies Reports 2.4 Inches Snowpack Increase for Winter 2026

2026-02-12 (ET)

08:50:00

Rain Enhancement Technologies Achieves Measurable Snowpack Increase in Utah

2026-02-05 (ET)

08:30:00

Rain Enhancement Technologies Launches Research to Remove Air Pollution

News

RAIN FAQ — answered by Alphio AI

Rain Enhancement Technologies Holdco, Inc. is engaged in developing rainfall generation technology. The Company is focused on developing, manufacturing and commercializing ionization rainfall generation technology to provide additional rainfall for industries, supranational organizations, countries and localities. It focuses on building its core platform with software, meteorology, hardware, product design and operations to make rainfall generation more dependable. It focuses on improving on existing rainfall generation technologies by introducing measurement tools, including automation technology, rain gauges, and weather stations. The rainfall generation platform ionizes the surrounding air similar to how air purifiers work. It intends to enhance agricultural, industrial and household water supplies for all the communities in which it operates by developing technology and services to serve governmental and commercial clients’ needs. It operates in the Industrials sector (PHARMACEUTICAL PREPARATIONS industry).

Rain Oncology Inc. is not a good buy right now due to its significant financial losses and lack of revenue. The stock has a current price of 0.98, a year-to-date change of -80.30%, and a forward P/E ratio of 0, indicating no expected earnings growth. The main risk is its negative net income of -3,246,657 in the latest quarter, which raises concerns about its financial viability.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten